Company Overview and News

 
Korab Resources to start drilling for cobalt, zinc at Batchelor

2017-02-20 proactiveinvestors.com.au
Korab Resources (ASX:KOR) is commencing a follow-up drilling program to further test cobalt and zinc mineralisation at its Batchelor project in the Rum Jungle Mineral Field near Darwin.

 
Korab Resources tops ASX % Gainers intra-day

2017-02-10 proactiveinvestors.com.au
Proactive Investors is a global leader in financial news, media, research and events focusing on emerging growth companies across four continents.

 
Korab Resources among ASX % Gainers intra-day

2017-02-10 proactiveinvestors.com.au
Proactive Investors is a global leader in financial news, media, research and events focusing on emerging growth companies across four continents.

 
Korab Resources Ltd confirms exploration potential of Rum Jungle project

2016-11-23 proactiveinvestors.com.au
The project is located 70 kilometres south of Darwin near the town of Batchelor in the Northern Territory. High grade zinc, lead and silver intercepts occur at White Bomb/Glen Luckie prospects in the similar setting as the Woodcutters zinc, lead and silver mine located 8 kilometres to the north. The zinc, lead and silver drilling results are encouraging, both for the possibilities they present for finding orebodies and for large base metal deposits.

 
Korab Resources Ltd receives Rum Jungle tenement grant offer

2016-11-13 proactiveinvestors.com.au
The lease area is located 70 kilometres south of Darwin near the town of Batchelor in the Northern Territory.

 
David Baker's 3 Must-Haves For The New Generation Of Gold Companies: Accountability, Accountability And Accountability

2016-09-19 seekingalpha
Mining companies have lost the trust of investors, says David Baker, managing partner at Baker Steel. Baker sees the gold market at a watershed point and the miners must change to stay afloat. In this interview with The Gold Report, Baker sets out his prescription for nursing the industry back to health. Will the restrictions his company and other investors are putting on gold companies increase reporting clarity, investor trust and money earned?

 
Quarterly Cashflow Report

2016-05-02 asx.com.au

 
Quarterly Activities Report

2016-05-02 asx.com.au

 
Korab denies Winchester risk from gold

2016-03-24 news.theage.com.au
JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.

 
Korab denies Winchester risk from gold

2016-03-24 news.smh.com.au
JavaScript disabled. Please enable JavaScript to use My News, My Clippings, My Comments and user settings.

 
Korab Resources Ltd is funded to develop Winchester magnesium carbonate project

2016-03-23 proactiveinvestors.com.au
Korab Resources Ltd (ASX:KOR) is a mining and exploration company with mineral assets and projects in Australia and Europe.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...